Drug maker Junshi seeks Swiss cure for cash woes 虧損陰霾不散 君實發GDR籌34億
The biotech aims to raise 3.4 billion yuan through Swiss GDRs in its second major fund-raising push in just over six months 這家生物製藥公司計劃到瑞士發行GDR籌資34億元，是短短半年來的第二次大額融資。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.